Biblio

Found 12 results
Filters: Keyword is Logistic Models  [Clear All Filters]
2013
H. Yun Park, Churg, A., Wright, J. L., Li, Y., Tam, S., Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., and Sin, D. D., Club cell protein 16 and disease progression in chronic obstructive pulmonary disease., Am J Respir Crit Care Med, vol. 188, no. 12, pp. 1413-9, 2013.
T. Zhang, M Smith, A., Camp, P. G., and Carleton, B. C., High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada., Pharmacoepidemiol Drug Saf, vol. 22, no. 7, pp. 744-51, 2013.
J. M. Schuetz, Daley, D., Leach, S., Conde, L., Berry, B. R., Gallagher, R. P., Connors, J. M., Gascoyne, R. D., Bracci, P. M., Skibola, C. F., Spinelli, J. J., and Brooks-Wilson, A. R., Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development., PLoS One, vol. 8, no. 9, p. e75170, 2013.
H. O. Coxson, Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. Ma, Celli, B., Crim, C., Duvoix, A., Fauerbach, P. Nasute, Lomas, D. A., MacNee, W., Mayer, R. J., Miller, B. E., Müller, N. L., Rennard, S. I., Silverman, E. K., Tal-Singer, R., Wouters, E. Fm, and Vestbo, J., The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study., Lancet Respir Med, vol. 1, no. 2, pp. 129-36, 2013.
D. D. Sin, C Tammemagi, M., Lam, S., Barnett, M. J., Duan, X., Tam, A., Auman, H., Feng, Z., Goodman, G. E., Hanash, S., and Taguchi, A., Pro-surfactant protein B as a biomarker for lung cancer prediction., J Clin Oncol, vol. 31, no. 36, pp. 4536-43, 2013.